We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

32 hedge funds and large institutions have $86.3K invested in Ampio Pharmaceuticals Inc. in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,300% more call options, than puts

Call options by funds: $192K | Put options by funds: $3K

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

66% less funds holding

Funds holding: 95 → 32 (-63)

90% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 69

95% less capital invested

Capital invested by funds: $1.77M → $86.3K (-$1.68M)

Holders
32
Holders Change
-63
Holders Change %
-66.32%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
8
Closed
69
Calls
$192K
Puts
$3K
Net Calls
+$189K
Net Calls Change
+$128K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$19K
2
HF
HRT Financial
New York
+$4.15K
3
UBS Group
UBS Group
Switzerland
+$3.67K
4
ARG
Advisory Resource Group
Oklahoma
+$3.23K
5
Citadel Advisors
Citadel Advisors
Florida
+$1.08K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$602K
2
BlackRock
BlackRock
New York
-$281K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$99K
4
PCMC
Private Capital Management (Colorado)
Colorado
-$57K
5
SA
Shilanski & Associates
Alaska
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
– -$6K -352 Closed
NWM
52
Northcape Wealth Management
New York
– -$6K -327 Closed
CAPTRUST Financial Advisors
53
CAPTRUST Financial Advisors
North Carolina
– -$5K -301 Closed
EWM
54
Empirical Wealth Management
Washington
– -$5K -277 Closed
UCFA
55
United Capital Financial Advisors
Texas
– -$5K -253 Closed
RJA
56
Raymond James & Associates
Florida
– -$4K -238 Closed
LP
57
LMR Partners
United Kingdom
– -$4K -232 Closed
DIA
58
Dana Investment Advisors
Wisconsin
– -$4K -217 Closed
RJFSA
59
Raymond James Financial Services Advisors
Florida
– -$4K -213 Closed
LPL Financial
60
LPL Financial
California
– -$4K -200 Closed
IWM
61
IHT Wealth Management
Illinois
– -$4K -197 Closed
SBIA
62
Sheaff Brock Investment Advisors
Indiana
– -$3K -190 Closed
Verition Fund Management
63
Verition Fund Management
Connecticut
– -$3K -175 Closed
Goldman Sachs
64
Goldman Sachs
New York
– -$3K -159 Closed
FHA
65
Flagship Harbor Advisors
Massachusetts
– -$3K -156 Closed
SFG
66
SNS Financial Group
Minnesota
– -$2K -133 Closed
BC
67
Bartlett & Co
Ohio
– -$2K -127 Closed
BCWM
68
Bartlett & Co Wealth Management
Ohio
– -$2.3K -127 Closed
SIG
69
Stonegate Investment Group
Alabama
– -$2K -100 Closed
Commonwealth Equity Services
70
Commonwealth Equity Services
Massachusetts
– -$1K -98 Closed
CCB
71
Cutter & Co Brokerage
Missouri
– -$2K -95 Closed
TSS
72
Two Sigma Securities
New York
– -$2K -91 Closed
ACM
73
Avalon Capital Management
California
– -$2K -88 Closed
TW
74
TrinityPoint Wealth
Connecticut
– -$2K -87 Closed
OC
75
Oppenheimer & Co
New York
– -$2K -83 Closed
1 2
3
4

AMPE Hedge Fund Activity: Q4 2022 in Review

32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2022, worth a combined $86.3K — down 95% from $1.77M a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of AMPE and 7 opened new positions — a net loss of 62 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Susquehanna International Group, adding an estimated $19K. The largest seller was Vanguard Group, exiting entirely with an estimated $602K sold.

  • 32 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2022, down from 95 in Q3 2022.
  • Funds reported $86.3K of Ampio Pharmaceuticals Inc. stock for Q4 2022, down 95% quarter-over-quarter.
  • 7 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2022 and 69 closed out, a net change of -62 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2022 was Susquehanna International Group, an estimated $19K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2022 was Vanguard Group, an estimated $602K sold.

Based on aggregated 13F filings for Q4 2022.